Genmont Biotech Inc operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Genmont Biotech Inc with three other
companies in this sector in Taiwan:
Abnova (Taiwan) Corporation
sales of 426.02 million Taiwanese Dollars [US$13.91 million]
of which 27%
was Monoclonal Antibodies),
(282.21 million Taiwanese Dollars [US$9.21 million]
Mycenax Biotech Incorporated
(211.42 million Taiwanese Dollars [US$6.90 million]
of which 100%
was Biological Drug Development).
Genmont Biotech Inc reported sales of 406.53 million Taiwanese Dollars (US$13.27 million)
December of 2018.
decrease of 26.5%
versus 2017, when the company's sales were 552.94 million Taiwanese Dollars.